Nearly a third of RRMS patients experiencing PIRA see their disability improve later, reducing their risk of progressing to ...

People with MS have a higher risk of dying by suicide than the general population, according to a meta-analysis of published ...

Simultaneously measuring levels of two blood proteins may help monitor both disease activity and disability progression in ...

A Phase 2 clinical trial testing PIPE-307, an MS experimental therapy designed to promote myelin repair, failed to meet its ...

A clinical trial testing an experimental vaccine for the Epstein-Barr virus (EBV) in people with MS is now recruiting ...

Tyruko, the first biosimilar of Tysabri, is now available in the U.S., providing a lower-cost treatment option for adults ...

Oligodendrocytes may show early immune-like changes in multiple sclerosis (MS), according to findings from a mouse study.

Mesenchymal stem cell therapy shows promise for treating MS, but more research is needed on long-term safety and efficacy, a ...

MS and MOGAD share similar symptoms but are two biologically distinct conditions, with different immune signatures, a study ...

Guest writer Shara Sand says that her severe mood changes went unidentified until a psychiatrist diagnosed her with bipolar ...

As Thanksgiving approaches, columnist Leigh Anne Nelson is focused on what gratitude really means and appreciating the small ...

Maybe healing after an MS relapse isn't in striving to feel better, but is found in savoring where you are now, writes ...